These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 29477396

  • 1. ISPOR's Initiative on US Value Assessment Frameworks: A Missed Opportunity for ISPOR and Patients.
    Perfetto EM.
    Value Health; 2018 Feb; 21(2):169-170. PubMed ID: 29477396
    [No Abstract] [Full Text] [Related]

  • 2. ISPOR's Initiative on US Value Assessment Frameworks: An Industry Perspective.
    Burkholder R, Dougherty JS, Neves LA.
    Value Health; 2018 Feb; 21(2):173-175. PubMed ID: 29477398
    [No Abstract] [Full Text] [Related]

  • 3. ISPOR's Initiative on US Value Assessment Frameworks: Seeking a Role for Health Economics.
    Sculpher M.
    Value Health; 2018 Feb; 21(2):171-172. PubMed ID: 29477397
    [No Abstract] [Full Text] [Related]

  • 4. ISPOR's Initiative on US Value Assessment Frameworks: The Use of Cost-Effectiveness Research in Decision Making among US Insurers.
    Solow B, Pezalla EJ.
    Value Health; 2018 Feb; 21(2):166-168. PubMed ID: 29477395
    [No Abstract] [Full Text] [Related]

  • 5. A Health Economics Approach to US Value Assessment Frameworks-Summary and Recommendations of the ISPOR Special Task Force Report [7].
    Garrison LP, Neumann PJ, Willke RJ, Basu A, Danzon PM, Doshi JA, Drummond MF, Lakdawalla DN, Pauly MV, Phelps CE, Ramsey SD, Towse A, Weinstein MC.
    Value Health; 2018 Feb; 21(2):161-165. PubMed ID: 29477394
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A Health Economics Approach to US Value Assessment Frameworks-Introduction: An ISPOR Special Task Force Report [1].
    Neumann PJ, Willke RJ, Garrison LP.
    Value Health; 2018 Feb; 21(2):119-123. PubMed ID: 29477388
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Reflections on the ISPOR Special Task Force on U.S. Value Frameworks: Implications of a Health Economics Approach for Managed Care Pharmacy.
    Garrison LP, Neumann PJ, Willke RJ.
    J Manag Care Spec Pharm; 2019 Nov; 25(11):1185-1192. PubMed ID: 31663458
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Reflections: NICE, health economics, and outcomes research.
    Rawlins M.
    Value Health; 2012 May; 15(3):568-9. PubMed ID: 22583468
    [No Abstract] [Full Text] [Related]

  • 17. As Value Assessment Frameworks Evolve, Are They Finally Ready for Prime Time?
    Dubois RW, Westrich K.
    Value Health; 2019 Sep; 22(9):977-980. PubMed ID: 31511186
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Recommendations on evidence needed to support measurement equivalence between electronic and paper-based patient-reported outcome (PRO) measures: ISPOR ePRO Good Research Practices Task Force report.
    Coons SJ, Gwaltney CJ, Hays RD, Lundy JJ, Sloan JA, Revicki DA, Lenderking WR, Cella D, Basch E, ISPOR ePRO Task Force.
    Value Health; 2009 Jun; 12(4):419-29. PubMed ID: 19900250
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.